Impact of cancer awareness campaigns in Peru: a 5-year Google Trends analysis.
Google Trends
Peru
cancer awareness
cancer trends
Journal
Ecancermedicalscience
ISSN: 1754-6605
Titre abrégé: Ecancermedicalscience
Pays: England
ID NLM: 101392236
Informations de publication
Date de publication:
2022
2022
Historique:
received:
15
03
2022
entrez:
23
2
2023
pubmed:
24
2
2023
medline:
24
2
2023
Statut:
epublish
Résumé
The aim of this research was to characterise the interest on the most frequent cancers in Peru through Google Trends, its geographic and temporal relationship with massive awareness campaigns. A temporal trends analysis for the last 5 years was carried out, comparing the Relative Search Volume (RSV) with the dates of mass cancer awareness campaigns in Peru. Google Trends application was used to evaluate the interest in the topics: breast, prostate, cervical stomach and colorectal cancer between 1 January 2016 and 31 December 2020, expressed in RSV. The annual RSV for each neoplasm was compared, as well as its annual variation using the Kruskal-Wallis test. The correlation between the RSV and the estimated incidence for each province was measured using the Spearman test. The topics with the highest RSV were breast (median: 20, range: 6-100) and prostate cancer (median: 28, range: 9-48). The topic 'breast cancer' showed a cyclical punctual increase in October, its awareness month. Searches for cervical, stomach and colorectal cancer were smaller and did not show peaks of interest. It was observed that the RSV was variable when compared with previous years ( This study suggests a positive temporal correlation between RSV and awareness cancer campaigns in Peru specially to breast cancer and, to a lesser extent, prostate cancer. Significant variations of interest were demonstrated for each neoplasm among the evaluated years. No significant correlation was found between the incidence rate and the average RSV among Peruvian provinces.
Sections du résumé
Background
UNASSIGNED
The aim of this research was to characterise the interest on the most frequent cancers in Peru through Google Trends, its geographic and temporal relationship with massive awareness campaigns.
Methods
UNASSIGNED
A temporal trends analysis for the last 5 years was carried out, comparing the Relative Search Volume (RSV) with the dates of mass cancer awareness campaigns in Peru. Google Trends application was used to evaluate the interest in the topics: breast, prostate, cervical stomach and colorectal cancer between 1 January 2016 and 31 December 2020, expressed in RSV. The annual RSV for each neoplasm was compared, as well as its annual variation using the Kruskal-Wallis test. The correlation between the RSV and the estimated incidence for each province was measured using the Spearman test.
Results
UNASSIGNED
The topics with the highest RSV were breast (median: 20, range: 6-100) and prostate cancer (median: 28, range: 9-48). The topic 'breast cancer' showed a cyclical punctual increase in October, its awareness month. Searches for cervical, stomach and colorectal cancer were smaller and did not show peaks of interest. It was observed that the RSV was variable when compared with previous years (
Conclusions
UNASSIGNED
This study suggests a positive temporal correlation between RSV and awareness cancer campaigns in Peru specially to breast cancer and, to a lesser extent, prostate cancer. Significant variations of interest were demonstrated for each neoplasm among the evaluated years. No significant correlation was found between the incidence rate and the average RSV among Peruvian provinces.
Identifiants
pubmed: 36819814
doi: 10.3332/ecancer.2022.1477
pii: can-16-1477
pmc: PMC9934880
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1477Informations de copyright
© the authors; licensee ecancermedicalscience.
Déclaration de conflit d'intérêts
None.
Références
BMJ. 2015 Jan 25;350:h450
pubmed: 25622600
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Med Internet Res. 2017 Oct 16;19(10):e344
pubmed: 29038096
Rev Peru Med Exp Salud Publica. 2013 Mar;30(1):124-8
pubmed: 23612825
J Med Internet Res. 2018 Jan 08;20(1):e6
pubmed: 29311051
Ecancermedicalscience. 2019 Sep 24;13:963
pubmed: 31645890
Curr Probl Cancer. 2022 Feb;46(1):100766
pubmed: 34304883
JMIR Public Health Surveill. 2017 Apr 06;3(2):e17
pubmed: 28385679
J Med Internet Res. 2021 Jun 15;23(6):e27052
pubmed: 34128824
JMIR Public Health Surveill. 2016 Apr 28;2(1):e17
pubmed: 27227152
J Am Coll Radiol. 2020 Nov;17(11):1520-1524
pubmed: 32645288
Ecancermedicalscience. 2020 Dec 10;14:1154
pubmed: 33574899
Cancer Epidemiol. 2019 Feb;58:193-198
pubmed: 30522779
Lancet Oncol. 2017 Oct;18(10):e573-e586
pubmed: 28971824
Dermatology. 2019;235(4):346-347
pubmed: 30999301
BMC Cancer. 2020 Dec 1;20(1):1173
pubmed: 33261561
BMC Public Health. 2019 May 03;19(1):503
pubmed: 31053073
Frontline Gastroenterol. 2017 Oct;8(4):290-294
pubmed: 29067156
Cureus. 2019 Aug 10;11(8):e5360
pubmed: 31608195
J Natl Cancer Inst. 2022 Jul 11;114(7):1036-1039
pubmed: 34291289
Crit Rev Oncol Hematol. 2019 Feb;134:22-30
pubmed: 30771870
BMJ Open. 2019 Jul 23;9(7):e029638
pubmed: 31340970
Health Policy. 2019 Mar;123(3):338-341
pubmed: 30660346
Ecancermedicalscience. 2020 Apr 20;14:1025
pubmed: 32346391
Cancer Res Treat. 2020 Jan;52(1):207-217
pubmed: 31291712
Ir J Med Sci. 2020 Aug;189(3):811-815
pubmed: 31838732
Asian Pac J Cancer Prev. 2019 May 25;20(5):1427-1432
pubmed: 31127903
JMIR Public Health Surveill. 2016 Oct 12;2(2):e156
pubmed: 27733330
Int J Cancer. 2021 Mar 1;148(5):1172-1182
pubmed: 32875560
J Glob Health. 2020 Jun;10(1):010403
pubmed: 32373327
Surg Endosc. 2021 Jan;35(1):398-405
pubmed: 32016518
Urology. 2020 May;139:64-70
pubmed: 32001306
BJU Int. 2019 Apr;123(4):595-601
pubmed: 30281883